3 terminated. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 3 | Terminated 3 |
Follow Hemiplegia: new trials by email Literature Review of Hemiplegia trials Research Report on Hemiplegia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity Phase 2; Low Dose MYOBLOC (10,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity, Cerebrovascular Accident | Phase 2 / Phase 3 | Terminated | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 32 | 2021-11-02 | 2026-05-27 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity Phase 2; Low Dose MYOBLOC (15,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity | Phase 2 / Phase 3 | Terminated | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 40 | 2019-12-17 | 2026-05-22 |
| Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation(rTMS) on the Recovery After Stroke repetitive transcranial magnetic stimulation (rTMS) - Stroke, Hemiplegia | Phase 2 / Phase 3 | Terminated | Seoul National University Bundang Hospital | 2 | 2011-01-01 | 2015-05-19 |
Stroke (3) · Brain Injuries, Traumatic (2) · Muscle Spasticity (2) · Cerebral Palsy (1) · Cerebrovascular Disorders (1) · Multiple Sclerosis (1)
Brain Diseases (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Paralysis (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Vascular Diseases (3) · Brain Injuries (2) · Cerebrovascular Disorders (2) · Craniocerebral Trauma (2) · Muscle Hypertonia (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2)
Clinical Trials, Phase II as Topic (2) · Clinical Trials, Phase III as Topic (2) · rimabotulinumtoxinB (2) · Transcranial Magnetic Stimulation (1)
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC (2) · Seoul National University Bundang Hospital (1)
Hungary (2) · Poland (2) · United States (2) · South Korea (1)
Joseph T Hull, PhD (2) · Nam-Jong Paik, MD, PhD (1)